tiprankstipranks
Trending News
More News >
Clal Biotechnology Industries Ltd (IL:CBI)
:CBI
Israel Market

Clal Biotech (CBI) Income Statement

Compare
0 Followers

Clal Biotech Income Statement

Last quarter (Q4 2023), Clal Biotech's total revenue was 16.00K, a decrease of -68.00% from the same quarter last year. In Q4, Clal Biotech's net income was -16.74M. See Clal Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
104.00K 370.00K 76.96M 74.54M 113.29M
Gross Profit
104.00K 370.00K 10.72M 6.22M 55.39M
Operating Expenses
10.29M 12.88M 77.47M 67.17M 67.83M
Depreciation and Amortization
526.00K 17.64M 22.51M 23.87M 21.02M
EBITDA
-24.02M 64.22M -78.69M 13.23M -58.84M
Operating Income
-10.18M 100.61M -101.20M -83.64M -79.86M
Other Income/Expenses
-17.91M -48.40M -26.92M 60.48M -345.51M
Pretax Income
-28.09M 52.21M -128.12M 49.84M -357.94M
Net Income
-31.05M -61.74M -89.58M 109.03M -154.11M
Per Share Metrics
Basic EPS
-0.20 -0.39 -0.57 0.68 -0.96
Diluted EPS
-0.20 -0.39 -0.57 0.68 -0.96
Weighted Average Shares Outstanding
156.85M 156.85M 158.44M 161.24M 161.24M
Weighted Average Shares Outstanding (Diluted)
156.85M 156.85M 158.44M 161.24M 161.24M
Currency in ILS

Clal Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis